Predict your next investment

Binx Health company logo
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
mybinxhealth.com

See what CB Insights has to offer

Founded Year

2005

Stage

Series E | Alive

Total Raised

$203.5M

Last Raised

$104M | 6 mos ago

About Binx Health

Binx Health is an in vitro diagnostics Point-of-Care (POC) company that provides at-home STI testing. The platform also includes evidence-based testing, counseling, treatment, and follow up in order to increase screening and reduce infections.

Binx Health Headquarter Location

245 First St

Cambridge, Massachusetts, 02142,

United States

646-847-8573

Latest Binx Health News

12:45 ET Worldwide Respiratory Infection Diagnostic Industry to 2025 - Featuring Abacus Diagnostics, Binx Health and Bio-Rad Lab...

Oct 6, 2021

News provided by Share this article Share this article COVID-19 has broken open the market for point of care testing of respiratory infections. Now the competition for market share begins in earnest. Large new markets are opening up. In health facilities, clinics, physicians' offices and elsewhere. And lets not forget the screening market, not just for COVID, but for the rest of the 20 something respiratory pathogens as well. Multiplex vs single plex? Explore the rapidly changing market as competitors jockey for position in new markets that are not yet well understood. New technology is forever changing the diagnosis of respiratory infections. Shrinking time to result is opening up markets multiple times the size of current microbiology based practice. Diagnosis has already moved into the Emergency Room. It is now moving to the Physician's Office Lab. Could the Home be next? The Multiplex factor is creating market confusion while lowering costs and improving care but important factors are holding back progress. The widespread nature of respiratory infections, (young people can get 8 colds a year) means that potential market sizes are enormous. Respiratory, already the largest infectious disease category could multiply in size. This is a growth opportunity for all diagnostic companies. Understand the opportunity and the risk with this in depth report. Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges. Key Topics Covered: 4.3.2 Bioinformatics Networking and Anonymous Reporting 4.4 Diagnostic Technology Development 4.4.2 Single Cell Genomics Changes the Picture 4.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 4.4.4 Pathogen Identification - A Projected Timetable of the Future 5 Respiratory Infection Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section 5.2 LGC Develops 'Ultra-High-Throughput' COVID Workflow 5.3 Cue Health Files for IPO for up to $100M 5.4 QuantuMDx Developing Multiplex System, Syndromic Panels 5.5 Bio-Rad Laboratories Gets CE Mark for Respiratory RT-PCR Assay Kit 5.6 BforCure Preparing Multiple Panels for PoC qPCR Platform 5.7 Angstrom Bio Raises $3M in Private Financing 5.8 Test for Them All 5.9 Hologic Banking on MDx Acquisitions 5.10 Pandemic Pushes Handheld qPCR Devices Closer to Commercialization 5.11 Talis Biomedical 2020 Revenues Rise Sharply 5.12 Luminex to Develop Covid/Flu/RSV Test 5.13 Becton Dickinson Charts Transition of COVID Diagnostics 5.14 MiRxes Receives Approval for Multiplex Covid/Flu Test 5.15 New Silicon-Based Test for Infectious Disease Screening 5.16 GenMark to Meet Demand for Respiratory Panel 5.17 Tempus Announces COVID-19 Testing, Data Initiative 5.18 Abacus Diagnostica Readying Multiplex Respiratory Test 5.19 Qiagen Acquires NeuMoDx Molecular 5.20 Companies Shift to Multiplex Tests for SARS-CoV-2, Influenza 5.21 Novacyt Gets CE Mark for Coronavirus, Flu, RSV Combo Panel 5.22 Cepheid Debuts 10-Color Technology With New Tuberculosis Test 5.23 BioMerieux's Pneumonia Panel Could Improve Care 5.24 Mammoth Biosciences Announces CRISPR-Based C19 Diagnostic 5.25 Genetic Signatures Gets CE Mark for C19 Molecular Test 5.26 Qiagen Respiratory Panel with C19 Receives CE Mark 5.27 Lumos Diagnostics Closes $15M Series A Funding 5.28 Fusion Genomics to Assess NGS Respiratory Tract Assay 5.29 C19 Test Development by Co-Diagnostics 5.30 Rapid Diagnostics Completes Purchase of Enigma Diagnostics 5.31 Flu-Like Epidemic Could Kill 80 Mn Globally 5.32 Startup developing AI for TB detection 5.33 Nipah Virus a Global Threat 5.34 Novacyt S.A.: New Respiratory Panel Ready for US Market 5.35 New DRC Ebola cases confirmed as FDA OKs Test 5.36 ResApp Awarded CE Mark for Phone-based Respiratory Test 5.37 Curetis Submits Lower Respiratory Tract Infection Test for FDA Clearance 5.38 New test diagnoses pneumonia and other lower respiratory infections 5.39 Ontera Awarded Contract for Zika Genotyping Test 5.40 Two New Members Join Global Diagnostics Network 5.41 BARDA Funding Health Security Solutions 6 Profiles of Key Players 6.1 Abacus Diagnostica

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Binx Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Binx Health is included in 5 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

961 items

Startups focused on providing products and services catering to women's health and wellbeing.

M

Medical Devices

11,214 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

3,299 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

11,293 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Binx Health Patents

Binx Health has filed 23 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Molecular biology techniques
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/18/2014

11/23/2021

Molecular biology, DNA, Biotechnology, Molecular biology techniques, Polymerase chain reaction

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/18/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/23/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, DNA, Biotechnology, Molecular biology techniques, Polymerase chain reaction

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Binx Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Binx Health Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.